期刊文献+

逆转录病毒载体介导的双耐药基因转染小鼠骨髓细胞的实验研究 被引量:1

Experimental study on mice bone marrow cells transferred with double-drug resistant gene by retroviral vectors
下载PDF
导出
摘要 目的:将耐药基因以逆转录病毒为载体转染骨髓细胞以解决大剂量化疗所造成的骨髓抑制。方法:以逆转录病毒为载体,将双突变的二氢叶酸还原酶基因(DH-FR)和胞苷脱氨基酶基因(CD)转染小鼠骨髓细胞,观察该细胞耐MTX及Ara-C的CFU-GM生成情况;RT-PCR检测转基因的表达情况。结果:转基因的小鼠骨髓细胞有耐药克隆形成(14%);基因转染后小鼠骨髓细胞对MTX和Ara-C的耐受明显增加,P<0·005;RT-PCR显示转基因细胞有转染的基因条带。结论:双耐药基因通过逆转录病毒转染小鼠骨髓细胞并且获得表达,提高了骨髓细胞对MTX和Aar-C的耐药性。 OBJECTIVE: To overcome the myelosupperssion caused by high dose chemotherapy by transfering drug resistance gene into bone marrow cells. METHODS: Double-mutant dihydrofolate reductase-cytidine deaminase gene was transferred into mouse bone marrow cells by retroviral vector. Colony-forming unit granulocyte-macrophage (CFU-GM) to MTX and Ara-C was gotten by cell culture. The expression of transferred drug resistance gene in mouse bone marrow cells was examined by RT-PCR. RESULTS: Yield of CFU-GM of transfected mouse bone marrow cells was 14 % and its drug resistance to both MTX and Ara-C was increased obviously, P〈0. 005. The expression of drug resistance gene in transfected mouse bone marrow cells was demonstrated by RT-PCR. CONCLUSIONS: Double drug resistance gene can not only integrate and express in mice bone marrow cells by retroviral vector but also increase the drug resistance to MTX and Ara-C.
出处 《中华肿瘤防治杂志》 CAS 2006年第14期1047-1049,共3页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30471678)
关键词 基因疗法 二氢叶酸还原酶基因 胞苷脱氨基酶基因 骨髓细胞 gene therapy dihydrofolate reductase cytidine deaminase bone marrow cells
  • 相关文献

参考文献9

  • 1Budak-Alpdogan T,Alpdogan O,Banerjee D,et al. Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene[J]. Mol ther,2004,10(3) :574-584. 被引量:1
  • 2Takebe N, Zhao S C, Ural A U, et al. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34 + - enriched peripheral blood progenitor cells[J]. Cancer Gene Ther, 2001,8(12):966-973. 被引量:1
  • 3Zhao S C, Banerjee D, Mineishi S, et al. Post transplant metrotrexate administration leadsto improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA [J].Human Gene Therapy,1997,8(8):903-909. 被引量:1
  • 4Koc O N, Reese J S, Davis B M, et al. DeltaMGMT- transduced bone marrow infusion increases tolerance to O6 -benzylguanine and 1,3 bis (2- chloroethyl ) - 1- nitrosourea and allows intensive therapy of 1,3 - his (2- chloroethyl ) -1-nitrosourea - resistant human colon cancer xenografts[J]. Hum Gene Ther, 1999,10(6):1021-1030. 被引量:1
  • 5Malech H L, Maples P B, Whiting-Theobald N, et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease[J]. Proc Natl Acad Sci USA, 1997,94(22):12133-12138. 被引量:1
  • 6Dunbar C E, Cottler-Fox M, O'Shaughnessy J A, et al. Retrovirally marked CD34- enriched peripheral blood and bone marrow cells contribute to long- term engraftment after autologous transplantation[J]. Blood, 1995,85(11):3048-3057. 被引量:1
  • 7Zhao S C, Li M X, Banerjce D, et al. Long-term protection of recipient mice from lethal dose of methotrexate by marrow infected with a double copy vector retrovirus containing amutant dihydrofolatere ductase[J]. Cancer Gene Ther, 1994,1(1):27-33. 被引量:1
  • 8Belur L R, Boelk-Galvan D, Diers M D, et al. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow[J].Cancer Res, 2001,15,61(4) : 1522-1526. 被引量:1
  • 9Takebe N, Xu L C, MacKenzie K L, et al. Methotrexate selection of long-term culture initiating cells following transduction of CD34 + cells with a retrovirus containing a mutated human dihydrofolate reductase gene[J]. Cancer Gene Ther, 2002, 9 (3) :308-320. 被引量:1

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部